NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.27
+0.36 (5.21%)
Jun 26, 2026, 4:00 PM EDT - Market closed
NeurAxis Employees
NeurAxis had 24 employees as of December 31, 2025. The number of employees increased by 3 or 14.29% compared to the previous year.
Employees
24
Change (1Y)
3
Growth (1Y)
14.29%
Revenue / Employee
$178,396
Profits / Employee
-$336,406
Market Cap
90.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24 | 3 | 14.29% |
| Dec 31, 2024 | 21 | 2 | 10.53% |
| Dec 31, 2023 | 19 | 1 | 5.56% |
| Dec 31, 2022 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
NRXS News
- 4 weeks ago - NeurAxis Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 4 weeks ago - NeurAxis Slides: Investor presentation - Filings
- 6 weeks ago - NeurAxis Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - NeurAxis Quarterly report: Q1 2026 - Filings
- 6 weeks ago - NeurAxis Earnings release: Q1 2026 - Filings
- 6 weeks ago - NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth - GlobeNewsWire
- 7 weeks ago - NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - GlobeNewsWire
- 2 months ago - NeurAxis Proxy statement: Proxy filing - Filings